Skip to main content

Advertisement

Log in

A Case of Scedosporium aurantiacum Infection in the United States

  • Case Report
  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Scedosporium aurantiacum is one of the emergent opportunistic fungal pathogens among immunocompromised hosts. Colonization of S. aurantiacum can also occur in patients with underlying lung diseases such as cystic fibrosis. S. aurantiacum is highly resistant to multiple antifungal agents, and management of the infected patients can be very challenging compared to those infected with other species of Scedosporium. Clinical cases have been geographically restricted mostly in Australia with a small number of cases identified in Europe and Japan. Although clinical isolates of S. aurantiacum from the USA have been included in several research studies, no clinical case of S. aurantiacum infection from the USA has been described. We report a case of S. aurantiacum infection acquired in the SA. Awareness of S. aurantiacum among healthcare providers and the species-level identification for Scedosporium are critically important for appropriate selection of antifungal agents and improvement of treatment outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008;21:157–97.

    Article  CAS  Google Scholar 

  2. Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F, et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis–a review. Med Mycol. 2009;47:387–97.

    Article  Google Scholar 

  3. Harun A, Serena C, Gilgado F, Chen SC-A, Meyer W. Scedosporium aurantiacum is as virulent as S. prolificans, and shows strain-specific virulence differences, in a mouse model. Med Mycol. Oxford Academic; 2010;48:S45–51.

  4. Wiederhold NP, Law D, Birch M. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans. J Antimicrob Chemother Oxford Academic. 2017;72:1977–80.

    Article  CAS  Google Scholar 

  5. Chen M, Zeng J, DeHoog GS, Stielow B, Gerrits Van Den Ende AHG, Liao W, et al. The ‘species complex’ issue in clinically relevant fungi: A case study in Scedosporium apiospermum. Fungal Biol. 2016;120:137–46.

    Article  Google Scholar 

  6. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Clinical Laboratory Standards Institute, M38 3rd Edition, 2017.

  7. Lackner M, de Hoog GS, Yang L, Ferreira Moreno L, Ahmed SA, Andreas F, et al. Proposed nomenclature for pseudallescheria. Scedosporium Relat Gen Fung Div. 2014;67:1–10.

    Article  Google Scholar 

  8. Gilgado F, Cano J, Gené J, Guarro J. Molecular phylogeny of the pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol. 2005;43:4930–42.

    Article  CAS  Google Scholar 

  9. Gilgado F, Serena C, Cano J, Gené J, Guarro J. Antifungal susceptibilities of the species of the pseudallescheria boydii complex. Antimicrob Agents Chemother. 2006;50:4211–3.

    Article  CAS  Google Scholar 

  10. Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, et al. Species-specific antifungal susceptibility patterns of scedosporium and pseudallescheria species. Antimicrob Agents Chemother. 2012;56:2635–42.

    Article  CAS  Google Scholar 

  11. Perfect JR. Treatment of non-aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis. 2005;40:S401–8.

    Article  CAS  Google Scholar 

  12. Nakamura Y, Suzuki N, Nakajima Y, Utsumi Y, Murata O, Nagashima H, et al. Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan. Respir Investig. 2013;51:207–11.

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank staff working in the Mycology Laboratory at the Johns Hopkins Hospital for their technical support for this case study.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

SZ and MM contributed to conceptualization. The first draft of the manuscript was written by MM. Sequencing analyses were performed by MT. All authors contributed to writing, reviewing and editing of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sean X. Zhang.

Ethics declarations

Conflict of intersts

The authors declare that they have no conflict of interest.

Additional information

Handling Editor: Vishnu Chaturvedi.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mizusawa, M., Totten, M. & Zhang, S.X. A Case of Scedosporium aurantiacum Infection in the United States. Mycopathologia 186, 127–130 (2021). https://doi.org/10.1007/s11046-020-00498-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-020-00498-x

Keywords

Navigation